author-photo

Joseph Dosch

University of Michigan

22

Papers

820

Citations

Citation Trend

Filter By

Papers (15) Sort By

Journal Conference Others

Targeting ADAM17 inhibits human colorectal adenocarcinoma progression and tumor-initiating cell frequency

2017 Oncotarget
Show All
- Source
- Cite
- Save
Citations (19)
Sensitivity of KRAS-Mutant Colorectal Cancers to Combination Therapy That Cotargets MEK and CDK4/6

2016 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (55)
Cancer Stem Cell Marker Phenotypes Are Reversible and Functionally Homogeneous in a Preclinical Model of Pancreatic Cancer

2015 Cancer Research
Show All
- Source
- Cite
- Save
Citations (16)
Abstract 1400: Evaluation of tumor-initiating cell populations in the KPC mouse model of pancreatic cancer

2015 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Modeling Selective Elimination of Quiescent Cancer Cells from Bone Marrow

2015 Neoplasia
Show All
- Source
- Cite
- Save
Citations (23)
Abstract 975: Monoclonal antibody targeting of ADAM17 is an effective treatment for metastatic colorectal cancer resulting in tumor growth control and reductions of cancer stem cells

2015 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Imaging Reporters for Proteasome Activity Identify Tumor- and Metastasis-Initiating Cells.

2015 Molecular Imaging
Show All
- Source
- Cite
- Save
Citations (12)
Abstract 1137: Bub1 is a key regulator of TGF-β signaling

2014 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract 4541: Dual targeting of CDK4 and MEK as a combination treatment strategy for metastatic colorectal cancer

2014 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract LB-257: c-Met: a new cancer stem cell marker and therapeutic target for pancreatic cancer

2010 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)